The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma
Oremek, G M, Teigelkamp, S, Kramer, W, Eigenbrodt, E, Usadel, K H
Published in Anticancer research (01.07.1999)
Get more information
Published in Anticancer research (01.07.1999)
Journal Article
Pre-analytical problems in the measurement of tumor type pyruvate kinase (tumor M2-PK)
Oremek, G M, Gerstmeier, F, Sauer-Eppel, H, Sapoutzis, N, Wechsel, H W
Published in Anticancer research (01.03.2003)
Get more information
Published in Anticancer research (01.03.2003)
Journal Article
Physical activity releases prostate-specific antigen (PSA) from the prostate gland into blood and increases serum PSA concentrations
Get full text
Journal Article
Conference Proceeding
Tumor M2-PK levels in haematological malignancies
Oremek, G M, Rox, St, Mitrou, P, Sapoutzis, N, Sauer-Eppel, H
Published in Anticancer research (01.03.2003)
Get more information
Published in Anticancer research (01.03.2003)
Journal Article
Value of the serum levels of the tumor marker TUM2-PK in pancreatic cancer
Oremek, G M, Eigenbrodt, E, Rädle, J, Zeuzem, S, Seiffert, U B
Published in Anticancer research (01.07.1997)
Get more information
Published in Anticancer research (01.07.1997)
Journal Article
Value of tumor M2 (Tu M2-PK) in patients with renal carcinoma
Oremek, G M, Sapoutzis, N, Kramer, W, Bickeböller, R, Jonas, D
Published in Anticancer research (01.11.2000)
Get more information
Published in Anticancer research (01.11.2000)
Journal Article
Aussagekraft von CRP, TNF und Tumormarkern bei Lungenerkrankungen
Get full text
Conference Proceeding